Karyopharm Therapeut (KPTI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 34,079 | 44,044 | 37,929 | 30,015 | 30,542 |
| Cost of Goods | 1,484 | 2,113 | 1,051 | 1,301 | 1,331 |
| Gross Profit | 32,595 | 41,931 | 36,878 | 28,714 | 29,211 |
| Operating Expenses | 50,923 | 57,264 | 61,316 | 62,271 | 60,823 |
| Operating Income | -17,844 | -15,220 | -24,387 | -33,256 | -31,281 |
| Interest Expense | 12,619 | 11,008 | 11,228 | 10,994 | 11,204 |
| Other Income | -71,802 | -6,865 | -1,597 | 20,824 | 11,596 |
| Pre-tax Income | -102,265 | -33,093 | -37,212 | -23,426 | -30,889 |
| Income Tax | -67 | 34 | 40 | 36 | -109 |
| Net Income Continuous | -102,198 | -33,127 | -37,252 | -23,462 | -30,780 |
| Net Income | $-102,198 | $-33,127 | $-37,252 | $-23,462 | $-30,780 |
| EPS Basic Total Ops | -7.02 | -3.82 | -4.32 | -2.77 | -2.97 |
| EPS Basic Continuous Ops | -7.01 | -3.82 | -4.32 | -2.77 | -3.65 |
| EPS Diluted Total Ops | -7.02 | -3.82 | -4.32 | -2.77 | -2.33 |
| EPS Diluted Continuous Ops | -7.01 | -3.82 | -4.32 | -2.77 | -2.65 |
| EPS Diluted Before Non-Recurring Items | -2.23 | -3.82 | -4.32 | -2.77 | -3.60 |
| EBITDA(a) | $-15,389 | $-12,336 | $-21,709 | $-30,841 | $-29,235 |